Track the latest Tempest Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Tempest Therapeutics stock.
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
Insiders have report no purchases/sales in the last 30 days.
There has been no Insider buying or selling in the last 90 days.
Aug 12, 2024 | Versant Venture Capital VI LPVersant Ventures VI GP LPVersant Ventures VI GPGP LLCVersant Vantage II LPVersant Vantage II GP LPVersant Vantage II GPGP LLCVersant Ventures IV LLCVersant Venture Capital IV LPVersant Side Fund IV LP | — | -788.00K | $1.23 | -$967.03K | SELL | -25.28% | 2.33M | Aug 08 - Aug 12 | View |
Jul 08, 2024 | Stephen Brady | PRESIDENT AND CEO | 35.00K | $2.11 | $73.85K | BUY | 307.67% | 46.38K | Jul 03 | View |
Jul 03, 2024 | Samuel Whiting | CHIEF MEDICAL OFFICER | 4.67K | $2.13 | $9.95K | BUY | 95.33% | 9.57K | Jul 02 | View |
Jul 02, 2024 | Justin Trojanowski | CORPORATE CONTROLLER | 7.50K | $2.16 | $16.20K | BUY | 51.13% | 22.17K | Jun 28 | View |
May 03, 2022 | Thomas Woiwode | DIRECTOR | 2.12M | $2.36 | $5.00M | BUY | 28719.59% | 2.13M | Apr 29 | View |
Jan 11, 2022 | Thomas W Dubensky | PRESIDENT | 2.00K | $4.78 | $9.56K | BUY | 1.80% | 113.34K | Jan 07 | View |
Jan 10, 2022 | Samuel Whiting | CHIEF MEDICAL OFFICER | 1.70K | $4.80 | $8.17K | BUY | 845.77% | 1.90K | Jan 06 | View |
Browse insider trades on all stocks.